India  

Pfizer

American multinational pharmaceutical corporation

Pfizer    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Pfizer: American multinational pharmaceutical corporation
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. The company was established in 1849 in New York by two German immigrants, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).

0
shares
ShareTweetSavePostSend
 
CDC Signs Off on COVID Vaccine Boosters for Kids Ages 5–11 [Video]

CDC Signs Off on COVID Vaccine Boosters for Kids Ages 5–11

CDC Signs Off on COVID Vaccine Boosters , for Kids Ages 5–11. CNN reports that on May 19, the CDC's Advisory Committee on Immunization Practices (ACIP)... . ... voted in support of recommending an..

Credit: Wibbitz Top Stories     Duration: 01:31Published
Pfizer’s COVID Booster Shot for 5 to 11 Year Olds Authorized by FDA [Video]

Pfizer’s COVID Booster Shot for 5 to 11 Year Olds Authorized by FDA

Pfizer’s COVID Booster Shot , for 5 to 11 Year Olds, Authorized by FDA. NBC News reports on May 17, the Food and Drug Administration (FDA)... … announced it had authorized Pfizer-BioNTech's..

Credit: Wibbitz Top Stories     Duration: 01:30Published
Pfizer's First Quarter Profits Blast Past 2022 Forecast [Video]

Pfizer's First Quarter Profits Blast Past 2022 Forecast

Pfizer's First Quarter , Profits Blast Past, 2022 Forecast. ABC reports that Pfizer's COVID-19 vaccine and treatment sales helped propel the pharmaceuticals company beyond Wall Street's first..

Credit: Wibbitz Top Stories     Duration: 01:31Published
Biden Administration Secures 20 Million Courses of Paxlovid [Video]

Biden Administration Secures 20 Million Courses of Paxlovid

Biden Administration Secures , 20 Million Courses of Paxlovid. Biden Administration Secures , 20 Million Courses of Paxlovid. CNN reports that on April 25, a senior administration official said , 20..

Credit: Wibbitz Top Stories     Duration: 01:30Published
Moderna Working on Vaccine Booster That Targets the Omicron Variant [Video]

Moderna Working on Vaccine Booster That Targets the Omicron Variant

Moderna Working on , Vaccine Booster That Targets, the Omicron Variant. The Associated Press reports that Moderna is developing an updated COVID-19 booster that offers protection against the omicron..

Credit: Wibbitz Top Stories     Duration: 01:30Published
Booster Shots in Children Ages 5–11 Increase Omicron Antibodies, Pfizer Says [Video]

Booster Shots in Children Ages 5–11 Increase Omicron Antibodies, Pfizer Says

Booster Shots in Children Ages 5–11 , Increase Omicron Antibodies, Pfizer Says. NBC News reports a booster shot of the Pfizer-BioNTech coronavirus vaccine increases antibody protection in children..

Credit: Wibbitz Top Stories     Duration: 01:30Published
Pfizer Issues Recall of Blood Pressure Medication [Video]

Pfizer Issues Recall of Blood Pressure Medication

Pfizer Issues Recall , of Blood Pressure Medication. Pfizer Issues Recall , of Blood Pressure Medication. Pfizer issued a recall of the blood pressure medication Accuretic on March 21. Other..

Credit: Wibbitz Top Stories     Duration: 01:30Published

You Might Like


Two Omicron sub-variants can trigger fresh Covid wave, says study; ICMR clears doubt on 4th coronavirus wave

Fourth wave: In a study, the scientists from several institutions found those vaccinated with Pfizer's shot were found to be better protected.
DNA - Published

Indian Covid vaccines better than Pfizer, Moderna: Adar Poonawalla

Serum Institute of India CEO Adar Poonawalla on Wednesday claimed that "Made in India" Covid vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and..
IndiaTimes - Published

Aurobindo gets licence to make generic version of Pfizer's oral antiviral Covid-19 pill nirmatrelvir

Pharma major Aurobindo Pharma Limited has inked a sub-license agreement with the UN-backed Medicines Patent Pool (MPP) for manufacturing and supplying a generic version of Pfizer’s Covid-19 oral..
IndiaTimes - Published

Pfizer vaccine less effective at preventing infection in younger than in older children, study suggests

pfizer vaccine less effective at preventing infection in younger than in older children, study suggests
A study suggests Pfizer jabs in children aged five to 11 were less effective at preventing infection than in children aged 12 to 17.
Sky News - Published

Pfizer sees revenues double to $81bn thanks to COVID-19 vaccine

pfizer sees revenues double to $81bn thanks to covid-19 vaccine
Drugs giant Pfizer has doubled annual sales and profits thanks to its COVID-19 vaccine.
Sky News - Published

MNCs tried to scuttle WHO nod for Covaxin: CJI Ramana

Chief Justice of India NV Ramana on Thursday lamented that attempts were made to prevent the indigenously developed Covaxin from getting WHO recognition. “Several multi-national companies, like..
IndiaTimes - Published

US-returned Mumbai man tests Omicron positive despite taking 3 doses of Pfizer vaccine

The 29-year-old man who tested Omicron positive took three doses of the Pfizer and Germany's BioNTech SE manufactured Comirnaty COVID vaccine in US.
DNA - Published

Pfizer's experimental COVID pill appears to work against Omicron variant, firm says

pfizer's experimental covid pill appears to work against omicron variant, firm says
Pfizer has said its experimental COVID-19 pill appears to be effective against the Omicron variant. 
Sky News - Published

Three doses of Pfizer vaccine can 'neutralise' Omicron variant, lab test shows

three doses of pfizer vaccine can 'neutralise' omicron variant, lab test shows
Three shots of the Pfizer/BioNTech COVID-19 vaccine has been shown to generate a neutralising effect against the new Omicron variant in a laboratory test.
Sky News - Published

'Just do it': Margaret Keenan's message one year after receiving first COVID jab

'just do it': margaret keenan's message one year after receiving first covid jab
The grandmother who made history when she got the Pfizer COVID jab exactly a year ago has urged anyone still to get vaccinated to "just do it" and help save lives.
Sky News - Published

Pfizer vaccine may be up to 40 times less effective against Omicron, first lab tests in South Africa suggest

The Pfizer vaccine may be up to 40 times less effective against Omicron than the original COVID strain, the first lab tests on the new variant in South Africa have shown.
Sky News - Published

COVID boosters will probably be needed for 'years to come', says Pfizer

covid boosters will probably be needed for 'years to come', says pfizer
People will probably need coronavirus booster jabs "for a number of years to come", a Pfizer boss has said.
Sky News - Published

Pfizer and Moderna jabs give best overall boost, UK study finds

pfizer and moderna jabs give best overall boost, uk study finds
The Pfizer and Moderna vaccines being used in the UK as boosters prompt the best overall response, according to a UK trial.
Sky News - Published

Covid-19: A wide range of vaccines act as booster to AstraZeneca, Pfizer shots, says study

Up to six different Covid-19 boosters were found to be safe, and provoked strong immune responses in people who have previously received a two-dose course of the Oxford-AstraZeneca-developed..
IndiaTimes - Published

BioNTech boss says 'don't freak out' about Omicron as Pfizer jab likely to protect against severe COVID

biontech boss says 'don't freak out' about omicron as pfizer jab likely to protect against severe covid
The Pfizer vaccine is likely to offer strong protection against any severe disease from the new Omicron COVID variant, according to the head of BioNTech who urged people not to 'freak out'.
Sky News - Published

New variant may force drug companies to tweak Covid vaccination plans

The emergence of the Omicron strain could lead drug companies scrambling to the drawing board to tweak their Covid-19 vaccine plans. US firm Novavax and Russia’s Gamaleya Institute said on Monday..
IndiaTimes - Published

New vaccines 'ready in 100 days' if Omicron variant is resistant to current jabs, Pfizer says

new vaccines 'ready in 100 days' if omicron variant is resistant to current jabs, pfizer says
Vaccine manufacturers have expressed confidence that they will be able to rapidly adapt their jabs if the Omicron variant spreads.
Sky News - Published

EU regulator authorises Pfizer COVID jab for children aged five to 11

eu regulator authorises pfizer covid jab for children aged five to 11
The European Union drugs regulator has authorised Pfizer’s coronavirus vaccine for use on children aged from five to 11.
Sky News - Published

Pfizer licence for new COVID pill could make treatment available to half world's population

pfizer licence for new covid pill could make treatment available to half world's population
Pfizer has signed a deal with a UN-backed group allowing other manufacturers to make its experimental COVID-19 pill, potentially making the drug available to more than half of the world's population.
Sky News - Published

Pfizer to allow generic versions of its Covid-19 pill in 95 countries


IndiaTimes - Published

Dr. Reddy's open to making Pfizer Covid pill after Merck deal


IndiaTimes - Published

COVID-19: Pfizer antiviral pill could be available 'early in 2022' if approved

An antiviral pill said to slash the risk of hospitalisation or death from COVID-19 should - subject to regulatory approval - be available early next year, the UK boss of Pfizer has told Sky News.
Sky News - Published

Pfizer's new COVID pill cuts hospitalisation or death by 89%, trial results indicate

Pfizer's new experimental COVID-19 antiviral pill cuts the risk of hospitalisation or death by 89%, the company has announced.
Sky News - Published

US approves Pfizer COVID vaccine for children as young as five

us approves pfizer covid vaccine for children as young as five
Children as young as five will be offered coronavirus vaccines in the US, after health officials gave the final sign-off to Pfizer's jab.
Sky News - Published

Benefits of giving Pfizer jab to 5-11-year-olds 'outweigh the risks'

benefits of giving pfizer jab to 5-11-year-olds 'outweigh the risks'
Benefits of giving the Pfizer/BioNTech COVID vaccine to 5 to 11-year-olds clearly outweigh the risks, according to a US drug watchdog.
Sky News - Published

Pfizer-BioNTech vaccine effectiveness wanes to 47% against COVID-19 infection after six months

pfizer-biontech vaccine effectiveness wanes to 47% against covid-19 infection after six months
Two doses of the Pfizer-BioNTech vaccine are 90% effective against COVID-19 hospitalisation for at least six months but only 47% effective against infection after that period, according to a new study.
Sky News - Published

With domestic manufacturing picking up pace, India unlikely to buy Pfizer, Moderna vaccines for now: Sources


IndiaTimes - Published

Pfizer COVID vaccine trial for children aged under 12 shows 'robust immune response'

pfizer covid vaccine trial for children aged under 12 shows 'robust immune response'
A Pfizer-BioNTech COVID-19 vaccine trial for children aged between five and 11 has produced "positive results" and has shown a "robust immune response", the two firms have said.
Sky News - Published

COVID-19 vaccine invites for 12 to 15-year-olds will start being sent out next week

The government has accepted the recommendation from the UK's chief medical officers that children aged 12 to 15 should be offered a first dose of the Pfizer/BioNTech coronavirus vaccine and invitations..
Sky News - Published

AstraZeneca and Pfizer safe to use as booster jabs, UK medicines regulator says

astrazeneca and pfizer safe to use as booster jabs, uk medicines regulator says
The UK's medicines regulator has said the Pfizer-BioNTech and Oxford-AstraZeneca coronavirus vaccines are safe to use as booster jabs.
Sky News - Published

COVID-19 pill administered in new Pfizer trial

covid-19 pill administered in new pfizer trial
US pharmaceutical giant Pfizer has started giving people doses of a pill against COVID-19 as part of a new clinical trial.
Sky News - Published

New Zealand reports its first death linked to Pfizer COVID jab

new zealand reports its first death linked to pfizer covid jab
New Zealand has reported its first death linked to the Pfizer vaccine after a woman suffered a rare side effect.
Sky News - Published

Blood clot risk much higher from COVID than from the vaccine, study finds

A coronavirus infection presents a much higher risk of developing a blood clot than a first dose of either the AstraZeneca or the Pfizer jab, a study has found.
Sky News - Published

Teenagers aged between 12 and 15 experienced mild to moderate side effects after Pfizer jab

teenagers aged between 12 and 15 experienced mild to moderate side effects after pfizer jab
Teenagers aged between 12 and 15 who had the Pfizer jab experienced mild to moderate side effects which cleared up quickly, a study has found.
Sky News - Published

Protection from COVID-19 jabs wanes within six months, study suggests

COVID-19 protection from two doses of the Pfizer or AstraZeneca vaccines begins to wane within six months, new research suggests.  
Sky News - Published

UK orders 35 million more doses of Pfizer vaccine as it prepares for COVID booster shots

uk orders 35 million more doses of pfizer vaccine as it prepares for covid booster shots
The UK has agreed to buy 35 million more doses of the Pfizer-BioNTech vaccine as it prepares to administer booster shots - while the head of the World Health Organisation (WHO) has said booster shots..
Sky News - Published

Lancet: Pfizer, AstraZeneca antibody levels start waning after six weeks


IndiaTimes - Published

COVID-19: EU approves Moderna's vaccine for kids aged 12-17 years

This is the second vaccine approved for use on children in Europe. The first vaccine by Pfizer/BioNTech was approved in May.
DNA - Published

Indian government's expert group in talks with Pfizer over Covid vaccine: Health minister


IndiaTimes - Published

Eight-week gap between first and second Pfizer doses 'a sweet spot', study finds

eight-week gap between first and second pfizer doses 'a sweet spot', study finds
An eight-week gap between the two doses of the Pfizer vaccine is a "sweet spot", according to new research.
Sky News - Published

Moderna and Pfizer jabs linked to mild heart inflammation but 'benefits still outweigh risks'

moderna and pfizer jabs linked to mild heart inflammation but 'benefits still outweigh risks'
The Pfizer/BioNTech and Moderna jabs have been linked to cases of mild heart inflammation - but the benefits still outweigh the risks, according to European and UK health agencies.
Sky News - Published

Pfizer's UK boss 'comfortable' with plan to lift COVID rules - but will continue to wear a face mask in crowded settings

pfizer's uk boss 'comfortable' with plan to lift covid rules - but will continue to wear a face mask in crowded settings
The UK boss of vaccine maker Pfizer says he is "comfortable" with the planned scrapping of most COVID-19 restrictions later this month - but he will continue to wear a mask in crowded settings.
Sky News - Published

India expects 3-4 million Pfizer, Moderna vaccine doses through Covax by August- sources

India expects to receive 3 million to 4 million doses of the Pfizer and Moderna Covid-19 shots through the Covax facility by August, two sources said, as it tries to expand inoculations to prevent..
IndiaTimes - Published

Indemnity issue holds up J&J, Pfizer and Moderna jabs


IndiaTimes - Published


 Page 1  〉